Apteki 36.6 (APTK) EBITDA margin MSFO (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | 5 years average | |||
| EBITDA margin, % | ? | 3.3% | 7.8% | 6.8% | 7.7% | 8.0% | 7.4% | ||
| Changes by years, y/y, % | -9pp | +5pp | -1pp | +1pp | +0pp | +7% | |||
Apteki 36.6. EBITDA margin, %
Apteki 36.6. EBITDA margin, changes, pp
Apteki 36.6 (APTK) EBITDA margin MSFO (quarter values) |
||||||||
| 2024Q2 | 2024Q4 | 2025Q2 | 2025Q4 | 2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 7.6% | 7.8% | 8.2% | 7.9% | 7.0% | 7.4% | |
| Changes by years, y/y, % | +1pp | +1pp | +1pp | +0pp | -1pp | |||
| Changes by quarters, q/q, % | +1pp | +0pp | +0pp | 0pp | -1pp | |||